Found: 17
Select item for more details and to access through your institution.
Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Oncologist, 2013, v. 18, n. 11, p. 1214, doi. 10.1634/theoncologist.2013-0168
- By:
- Publication type:
- Article
Outcomes After Combined Modality Therapy for EGFR-Mutant and Wild-Type Locally Advanced NSCLC.
- Published in:
- Oncologist, 2011, v. 16, n. 6, p. 886, doi. 10.1634/theoncologist.2011-0040
- By:
- Publication type:
- Article
Are ‘the destitute’ destitute? Understanding micro-inequalities through the concept of defiled surpluses.
- Published in:
- Environment & Urbanization, 2017, v. 29, n. 1, p. 251, doi. 10.1177/0956247816672159
- By:
- Publication type:
- Article
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1095, doi. 10.1634/theoncologist.2018-0695
- By:
- Publication type:
- Article
Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2570, doi. 10.1002/cncr.29397
- By:
- Publication type:
- Article
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 21, p. 3761, doi. 10.1002/cncr.28290
- By:
- Publication type:
- Article
Recurrent malignant peritoneal mesothelioma: radiological manifestations.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The Decline of Gangsters and Politicization of Violence in Urban Bangladesh.
- Published in:
- Development & Change, 2019, v. 50, n. 5, p. 1214, doi. 10.1111/dech.12428
- By:
- Publication type:
- Article
Fire Without Smoke: Lung Cancer in 'Never-Smokers'.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 1, p. 40
- By:
- Publication type:
- Article
European Society for Medical Oncology, ELCC 2015 European Lung Cancer Conference: Advisor’s Introduction.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. i, doi. 10.1177/1559897715588541
- By:
- Publication type:
- Article
Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 1, p. 225, doi. 10.1102/1470-7330.2012.0027
- By:
- Publication type:
- Article
Erlotinib Plus Bevacizumab in Previously Treated Patients With Malignant Pleural Mesothelioma.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 4, p. 808, doi. 10.1002/cncr.23617
- By:
- Publication type:
- Article
Response to low‐dose ketoconazole and subsequent dose escalation to high‐dose ketoconazole in patients with androgen‐independent prostate cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 975
- By:
- Publication type:
- Article
Treatment of peritoneal mesothelioma in pediatric patients.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 52, n. 1, p. 127, doi. 10.1002/pbc.21718
- By:
- Publication type:
- Article
EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Impact of EGFR mutations on treatment of non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, p. 5, doi. 10.1007/s00280-006-0309-3
- By:
- Publication type:
- Article